A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Published Feb 7, 2020

A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Overseen by the renowned immunologist Dr. Carl June, it showed the edited genes had a sustained ability to attack and kill tumors.

NOW
PLAYING
Cancer Doesn't Mean the End—Senator Harry Reid Talks To SurvivorNet About the Experimental New Therapy That Saved His Life
NOW
PLAYING
It's Imperative Black Cancer Patients Get Better Access to Clinical Trials
NOW
PLAYING
Some Cancer Patients Can Get Chemotherapy Without A Higher Risk Of COVID-19 Infection, Study Shows
NOW
PLAYING
Houston Coronavirus Crisis -- MD Anderson Taking in COVID-19 Cases-- What Cancer Patients Can Do
NOW
PLAYING
New Hope For Esophageal Cancer Patients -- Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer
NOW
PLAYING
The Urgent National Problem-- Too Many Cancer Patients Not Seeking Treatment-- The Fear of Leaving Home
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.